RTL Aktuell: Transcranial Pulse Stimulation (TPS) as a Hopeful Therapy Option
RTL reports on Shock Wave Therapy TPS for Alzheimer’s at Bonn University Hospital on World Alzheimer’s Day 2023
As part of World Alzheimer’s Day 2023, broadcaster RTL reported on September 21, 2023, in several formats, including the main news program “RTL Aktuell” on those two new therapeutic options for Alzheimer’s dementia that are currently the most talked about: Shock Wave Brain Stimulation Transcranial Pulse Stimulation (TPS) and anti-body medications such as Lecanemab.
RTL reported on this from the Neurocenter of the University Hospital Bonn (UBK) and interviewed Prof. Dr. med. Ullrich Wüllner, Director of the Clinic for Neurodegenerative Diseases, and let a patient and his partner have their say.
Prof. Wüllner and his team are researching Transcranial Pulse Stimulation and see in Alzheimer’s shock wave therapy good treatment options for Alzheimer’s patient:in: In the case of the interviewed patient, for example, the symptoms of Alzheimer’s disease have improved significantly; he and his partner speak of a miracle.
Alzheimer’s Shock Wave Therapy TPS: Stable course, patient feels “like new”
Prof. Wüllner summarizes in the interview, “We actually observe a stable course in two-thirds of our patients. That is, the mental performance, measured in the neurological test, does not get worse!”
In the German Center for Neurodegenerative Diseases (DZNE) research center in Bonn, one also researches new antibody drugs such as Lecanemab in clinical trials. In some patient:in, however, there are severe side effects such as brain hemorrhage. The current goal is to find out which patients could benefit from the antibody therapy, the preparations of which have not yet been approved in Europe. Prof. Wüllner: “We need more personalized medicine. The anti-bodies do not work the same way for every person affected.”
New therapies can significantly improve the lives of many Alzheimer’s patients
As yet, all promising new therapies must continue to be studied in large clinical trials. But with early diagnosis the lives of many Alzheimer’s patient:s may be significantly improved in the future, according to the report.
The following link leads to the article in the news program “RTL Aktuell” from September 21, 2023: